Spots Global Cancer Trial Database for flt
Every month we try and update this database with for flt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer | NCT00245349 | Head and Neck C... | F-18 Fluorothym... | 21 Years - | University of Iowa | |
| Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia | NCT03900949 | Acute Myeloid L... | Allogeneic Hema... Cytarabine Daunorubicin Hy... Gemtuzumab Ozog... Midostaurin | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia | NCT03900949 | Acute Myeloid L... | Allogeneic Hema... Cytarabine Daunorubicin Hy... Gemtuzumab Ozog... Midostaurin | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | NCT00721799 | Mouth Neoplasms Oropharyngeal N... Laryngeal Neopl... Head and Neck N... | 18F-Fluorothymi... | 18 Years - | University of Iowa | |
| Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer | NCT00934401 | Breast Neoplasm... | 18 Years - 100 Years | University of Iowa | ||
| F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | NCT00721799 | Mouth Neoplasms Oropharyngeal N... Laryngeal Neopl... Head and Neck N... | 18F-Fluorothymi... | 18 Years - | University of Iowa | |
| Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer | NCT00934401 | Breast Neoplasm... | 18 Years - 100 Years | University of Iowa | ||
| Personalized Translational Platform for Biomarker Discovery in Brain Tumors | NCT01240161 | High Grade Glio... | FLT-PET/CT: (3'... | 18 Years - 85 Years | Brigham and Women's Hospital | |
| The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | NCT01000428 | Erlotinib Lung Cancer | 18 Years - 85 Years | Asan Medical Center | ||
| FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib | NCT01143779 | Advanced Cancer | FLT-PET | 18 Years - | M.D. Anderson Cancer Center | |
| The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | NCT01000428 | Erlotinib Lung Cancer | 18 Years - 85 Years | Asan Medical Center | ||
| Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma | NCT03318497 | Pancreatic Aden... | 3'-deoxy-3'-[F-... Computed Tomogr... Positron Emissi... Laboratory Biom... | 18 Years - | University of Texas Southwestern Medical Center | |
| A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation | NCT00847509 | Lung Cancer Head and Neck C... | [F-18]FLT | 18 Years - | Siemens Molecular Imaging | |
| Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT | NCT01261585 | Bronchial Neopl... Carcinoma, Non-... | 18 Years - 75 Years | Centre Henri Becquerel | ||
| Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer | NCT00245349 | Head and Neck C... | F-18 Fluorothym... | 21 Years - | University of Iowa | |
| FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib | NCT01143779 | Advanced Cancer | FLT-PET | 18 Years - | M.D. Anderson Cancer Center | |
| Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx | NCT00767273 | Pancreatic Canc... | PET Scan FLT FDG | 18 Years - | Stanford University | |
| MRI and PET to Assess Pembrolizumab Response | NCT02591654 | Malignant Melan... | Pembrolizumab FLT PET | 18 Years - | Columbia University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
